In the MOTIF research project we aim to develop new nanobodies against a T-cell-specific membrane protein. These nanobodies will be conjugated on the envelope of viral vector, hereby selectively infecting and transducting the T-cells. We will additionally employ genetically-modified mice to test these engineered viral vectors in an optimal manner..
|Effective start/end date
|1/01/21 → 31/12/22
- T cells
- in situ
- Viral transduction
- Genetically-engineered mice
Flemish discipline codes in use since 2023
- Molecular and cell biology not elsewhere classified
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.